Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name:MC38-hFOLR1/hCD47(2) Strain State : Validation of tumorigenic capacity completed | Cat. NO.:NM-S13-TM87
FOLR1/CD47 gene humanized mouse colon adenocarcinoma cell.
Strain Name:MC38-hCLDN 18.2 Strain State : Validation of pharmacodynamic assays completed | Cat. NO.:NM-S13-TM10
These transgenic cells carry humanized CLAUDIN 18.2.
Strain Name:B16F10-hFAP Strain State : Validation of tumorigenic capacity completed | Cat. NO.:NM-S31A-TM03
These transgenic cells carry humanized FAP.
Strain Name:MC38-hFAP Strain State : Validation of tumorigenic capacity completed | Cat. NO.:NM-S13-TM11
Strain Name:CT26-hSIGLEC15 Strain State : Validation of pharmacodynamic assays completed | Cat. NO.:NM-S24A-TM04
These transgenic cells carry humanized SIGLEC15.
Strain Name:MC38-hSIGLEC15 Strain State : Construction | Cat. NO.:NM-S13-TG01
Model Organisms:小鼠 Product & Service:- Research field:
U-HuDTMbase® is composed of more than 600 therapeutic target-humanized mouse models, including multiple background strains, and has covered almost all commonly studied areas, such as oncology, metabolism, immunity, inflammation and more.
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Humanized mouse models preclinical research targeted therapies webinar oncology drug development preclinical therapeutic advancements immune system models animal modeling services
Join GenoBioTX's webinar on July 25th to explore the latest advancements in humanized mouse models for preclinical research. Learn how these models are transforming targeted therapy development across various diseases. Featuring expert insights from Dr. Derek Reznik, discover the generation and application of humanized immune system models in oncology drug development. Don't miss this opportunity to enhance your knowledge in cutting-edge preclinical therapeutic advancements. Register now!
Please fill in the order form and we will contact you within 2 working days.